PIZZA, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 14.949
AS - Asia 13.691
EU - Europa 8.728
SA - Sud America 738
AF - Africa 647
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 7
Totale 38.803
Nazione #
US - Stati Uniti d'America 14.753
SG - Singapore 3.877
VN - Vietnam 3.682
CN - Cina 3.135
GB - Regno Unito 2.014
IT - Italia 1.675
DE - Germania 1.306
HK - Hong Kong 1.158
SE - Svezia 748
FR - Francia 639
IN - India 634
BR - Brasile 545
RU - Federazione Russa 536
IE - Irlanda 346
UA - Ucraina 342
KR - Corea 277
JP - Giappone 231
ZA - Sudafrica 230
FI - Finlandia 205
NL - Olanda 200
CI - Costa d'Avorio 169
EE - Estonia 147
CH - Svizzera 119
CA - Canada 114
TG - Togo 114
ID - Indonesia 73
BE - Belgio 71
BG - Bulgaria 69
PH - Filippine 69
AR - Argentina 68
BD - Bangladesh 68
JO - Giordania 68
PL - Polonia 66
SC - Seychelles 64
MX - Messico 58
AT - Austria 55
TH - Thailandia 50
IQ - Iraq 48
TR - Turchia 48
PK - Pakistan 47
TW - Taiwan 43
EC - Ecuador 39
AU - Australia 38
ES - Italia 38
IR - Iran 25
GR - Grecia 24
RS - Serbia 23
UZ - Uzbekistan 22
SA - Arabia Saudita 21
CO - Colombia 19
CL - Cile 17
LB - Libano 17
MY - Malesia 16
LT - Lituania 15
RO - Romania 15
PY - Paraguay 14
TN - Tunisia 14
PE - Perù 13
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
DK - Danimarca 12
MA - Marocco 10
OM - Oman 10
NG - Nigeria 9
NP - Nepal 9
EG - Egitto 8
HR - Croazia 8
IL - Israele 8
KE - Kenya 8
SK - Slovacchia (Repubblica Slovacca) 8
AL - Albania 7
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
UY - Uruguay 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CR - Costa Rica 6
ET - Etiopia 6
NO - Norvegia 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
JM - Giamaica 5
KW - Kuwait 5
LU - Lussemburgo 5
PS - Palestinian Territory 5
BY - Bielorussia 3
CY - Cipro 3
DZ - Algeria 3
GH - Ghana 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
AM - Armenia 2
GF - Guiana Francese 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
ME - Montenegro 2
MU - Mauritius 2
Totale 38.772
Città #
Singapore 2.704
Fairfield 1.779
Southend 1.717
Ashburn 1.468
Hong Kong 1.088
Chandler 833
Ann Arbor 781
Ho Chi Minh City 780
Woodbridge 722
Seattle 671
Houston 660
San Jose 648
Hanoi 644
Wilmington 625
Hefei 612
Cambridge 569
Dong Ket 511
Princeton 475
Santa Clara 471
Beijing 404
Bologna 379
Dublin 346
Boardman 290
Los Angeles 272
Lauterbourg 260
Seoul 244
Tokyo 204
New York 196
Westminster 183
Nanjing 170
Abidjan 169
Jacksonville 164
Padova 155
Redmond 147
Council Bluffs 145
Helsinki 143
Berlin 137
Redondo Beach 133
Frankfurt am Main 126
Lomé 114
Da Nang 105
San Diego 105
Haiphong 104
Buffalo 103
Dallas 101
Saint Petersburg 97
Shenyang 93
Jinan 92
Milan 90
Bern 86
Bengaluru 78
Changsha 71
São Paulo 70
Rome 69
Sofia 67
Amman 66
Turin 66
Guangzhou 65
Hebei 64
Brussels 63
Shanghai 59
Tianjin 54
Nanchang 53
Johannesburg 52
Redwood City 51
Medford 50
Dearborn 49
Falls Church 49
Munich 49
Yubileyny 48
Toronto 45
Chicago 43
Jakarta 43
Phoenix 43
Des Moines 40
Florence 40
Lappeenranta 39
Mülheim 39
Biên Hòa 38
London 37
Atlanta 36
Can Tho 36
Zhengzhou 36
Braunschweig 35
Hải Dương 34
Nuremberg 34
Brooklyn 32
Montreal 32
Boston 31
Hangzhou 31
Orem 31
Pune 31
Taizhou 31
Warsaw 31
Vienna 30
Amsterdam 29
Jiaxing 29
The Dalles 29
San Francisco 28
Norwalk 27
Totale 25.348
Nome #
La sindrome delle gambe senza riposo in dialisi. Ruolo dell'infiammazione cronica 479
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 411
Biting behavior, aggression, and seizures 281
Actigraphic assessment of sleep/wake behavior in central disorders of hypersomnolence. 274
DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism 262
Automatic slow eye movement (SEM) detection of sleep onset in patients with obstructive sleep apnea syndrome (OSAS): comparison between multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT). 260
Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome. 257
Can smartphone sleep applications reliably assess sleep-wake cycle? Preliminary findings from a PSG study. 238
Automatic detection of cataplexy 237
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. 226
Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients 223
Age-related differences in sleep-dependent consolidation of motor skills in patients with narcolepsy type 1 220
An improved algorithm for the automatic detection and characterization of slow eye movements 218
Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases 218
Creativity in Narcolepsy Type 1: The Role of Dissociated REM Sleep Manifestations 218
Eating disorders in narcolepsy type 1: Evidence from a cross-sectional Italian study 215
Sexsomnia: a diagnostic challenge, a case report 215
Cardiovascular autonomic dysfunction, altered sleep architecture, and muscle overactivity during nocturnal sleep in pediatric patients with narcolepsy type 1 215
(Not so) Smart sleep tracking through the phone: Findings from a polysomnography study testing the reliability of four sleep applications 215
A driving simulation task: correlations with Multiple Sleep Latency Test. 213
Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency 211
Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease 209
Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases. 203
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. 203
Automatic Detection of Single Slow Eye Movements and Analysis of their Changes at Sleep Onset 202
Antibodies against hypocretin receptor 2 are rare in narcolepsy 202
Catathrenia under sodium oxybate in narcolepsy with cataplexy. 200
Mitochondrial abnormalities in fibroblasts carrying DNMT1 mutations 198
Cognitive dysfunction in central disorders of hypersomnolence: A systematic review 198
Autosomal dominant adult spinal muscular atrophy associated with alacrimia and achalasia. 196
Sleep Bruxism and Orofacial Pain in Patients with Sleep Disorders: A Controlled Cohort Study 195
The clinical spectrum of childhood narcolepsy 194
The burden of narcolepsy with cataplexy: How disease history and clinical features influence socio-economic outcomes. 193
Nocturnal Sleep Dynamics Identify Narcolepsy Type 1. 192
A case of fragile X premutation tremor/ataxia syndrome (FXTAS) with evidence of mitochondrial dysfunction 192
Cataplectic attacks during rapid eye movement sleep behavior disorder episodes in a narcoleptic patient. 192
A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD 191
Autonomic disturbances in narcolepsy. 188
Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management 188
Role of Daytime Continuous Polysomnography in the Diagnosis of Pediatric Narcolepsy Type 1 187
Common variants in P2RY11 are associated with narcolepsy 187
Cataplexy and ataxia: red flags for the diagnosis of DNA methyltransferase 1 mutation 187
Sleeping with spinal cord injury. 186
Phenomenology and psychiatric correlates of pseudocataplexy 185
Autism Spectrum Disorder and Narcolepsy: A Possible Connection That Deserves to Be Investigated. 185
The Distinguishing Motor Features of Cataplexy: A Study from Video Recorded Attacks 184
Periodic leg movements during sleep in narcoleptic patients with or without restless legs syndrome. 183
Increased interferon-mediated immunity following in vitro and in vivo Modafinil treatment on peripheral immune cells 183
Clinical and polysomnographic course of childhood narcolepsy with cataplexy. 183
Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic Restless Legs Syndrome patients. 180
Type 1 narcolepsy in anti-Hu antibodies mediated encephalitis: a case report 179
Can a Peer Support the Process of Self-Management in Narcolepsy? A Qualitative Narrative Analysis of a Narcoleptic Patient 179
Cerebral hemodynamic changes in stroke during sleep-disordered breathing. 177
Segmental hair testing of triazolam to unmask a suspected case of idiopathic recurrent Stupor 176
Car Crashes and Central Disorders of Hypersomnolence: A French Study. 176
Motor events during REM sleep in patients with narcolepsy-cataplexy: a video-polysomnographic pilot study. 175
Narcolepsy with cataplexy mimicry: the strange case of two sisters. 175
Slow eye movements distribution during nocturnal sleep. 175
In-field assessment of sodium oxybate effect in pediatric type 1 narcolepsy: An actigraphic study 175
Sex disparities in clinical features and burden of narcolepsy type 1 174
Rhythmic movements and sleep paralysis in narcolepsy with cataplexy: a video-polygraphic study. 173
The automatic detection of slow eye movements (SEMs): A new method for sleep onset detection 173
HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. 172
Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus 172
Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. 172
Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR) 172
Narcolepsy features in young patients 170
Cortical activation during sleep predicts dream experience in narcolepsy 170
Work productivity and activity impairment in patients with narcolepsy type 1 169
Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. 169
Narcolepsy is a common phenotype in HSAN IE and ADCA-DN 169
Charles Bonnet syndrome in hemianopia, following antero-mesial temporal lobectomy fordrug-resistant epilepsy 168
Family recurrence and oligo-anuria predict uremic restless legs syndrome. 168
Immune characterization in Narcolepsy Type 1. 168
Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning 168
Development of a disability scale for myotonic dystrophy type 1. 167
Rare Primary Mitochondrial DNA Mutations and Probable Synergistic Variants in Leber's Hereditary Optic Neuropathy. 167
Muscle Pain Sensitivity and Prevalence of Temporomandibular Disorders in Patients with Narcolepsy with Cataplexy: A Controlled Cohort Study 165
DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. 165
High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. 165
Sleep-related violence and sexual behavior in sleep: a systematic review of medical-legal case reports. 165
Combining Information on Nocturnal Rem Sleep Latency and Atonia to Facilitate Diagnosis of Pediatric Narcolepsy Type 1 165
Sodium oxybate treatment in pediatric type 1 narcolepsy 164
Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias 164
Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy. 163
Dream Generation and Recall in Daytime NREM Sleep of Patients With Narcolepsy Type 1 163
Aspects of functioning in people with narcolepsy identified by the ICF core set for sleep disorders: preliminary results 161
Increased prevalence of nocturnal smoking in restless legs syndrome (RLS). 160
Diffusion-weighted imaging study of patients with essential tremor. 160
Parental fitness questioned on the grounds of narcolepsy: Presentation of two cases 160
Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. 159
Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging. 157
Use and safety of nitrous oxide during lumbar puncture for the diagnosis of childhood narcolepsy 157
Sleep disorders in patients with spinal cord injury. 156
Response to the letter to the editor from Dr. Kawada, "Characteristics of patients with hypersomnia by actigraphy". 156
A preliminary quantitative analysis of REM sleep chin EMG in Parkinson's disease with or without REM sleep behavior disorder. 155
Decreased sleep stage transition pattern complexity in narcolepsy type 1 155
Non-24-hour sleep-wake rhythm disorder and melatonin secretion impairment in a patient with pineal cyst 155
Modulation of the muscle activity during sleep in cervical dystonia 154
A standardized test to document cataplexy 154
Totale 19.198
Categoria #
all - tutte 107.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.473 0 0 0 0 0 0 0 0 0 166 122 1.185
2021/20224.387 343 144 310 244 415 223 125 496 340 324 737 686
2022/20233.975 391 518 215 500 250 297 136 251 721 186 290 220
2023/20241.396 90 232 101 237 72 255 55 82 36 116 46 74
2024/20255.119 157 880 430 360 804 276 325 135 91 292 283 1.086
2025/202613.474 1.404 1.447 1.320 1.086 1.516 814 1.764 490 2.696 937 0 0
Totale 39.532